Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015. This represents about 12% of all new cancer cases and 25% of all cancers in women.
According to the World Health Organisation (Global Heath Estimates 2013), over 50% of breast cancer cases and 42% of deaths occur in developed countries. This includes the UK, where one in five cases of breast cancer results in a fatality.
This project therefore seeks to develop INTELLISCAN, an Artificial Intelligence, machine learning enhanced breast MRI scanning system for use as a highly efficient, more accurate breast cancer screening tool.
The technology applies computer based image processing to deliver improved, instant, automated anomaly detection of breast MRI scans.
It will provide a new innovative digital health solution that will ‘disrupt existing markets’ by changing the way that breast cancer MRI's scans are analysed, reported and actioned.